Zobrazeno 1 - 10
of 14
pro vyhledávání: '"T R, Andersson"'
Autor:
P. Andersen, T. R. Andersson, F. Wisløff, K. Løvåsen, C. Eika, B. Riis Strøm, G. E. Tjønnfjord, K. Fjæstad, E. Brandt, Bernt Ly
Publikováno v:
European Journal of Haematology. 47:333-337
All patients in the region with newly discovered M components were registered from 15 Aug. 1984-31 Dec. 1986. Among a total of 393 patients enrolled, 162 had multiple myeloma (MM). The incidence rate was 6.6 per 100,000 population per year (age-adjus
Publikováno v:
Journal of Biological Chemistry. 264:5128-5133
Heparin and dermatan sulfate increase the rate of inhibition of thrombin by heparin cofactor II (HCII) approximately 1000-fold by providing a catalytic template to which both the inhibitor and the proteinase bind. A variant form of HCII that binds he
Publikováno v:
Thrombosis and Haemostasis. 62:856-860
SummaryExtrinsic coagulation pathway inhibitor may be an important regulator of haemostasis to prevent thrombosis after tissue damage. The functional activity of this inhibitor was determined using a chromogenic substrate assay, and compared to the a
Autor:
Per Morten Sandset, T. R. Andersson
Publikováno v:
Journal of Internal Medicine. 225:311-316
The well-known coagulation inhibitors antithrombin and protein C, and the more recently described inhibitors, heparin cofactor II and extrinsic pathway inhibitor, were measured in plasma during a 7-day observation period, from patients with pneumonia
Publikováno v:
XIth International Congress on Thrombosis and Haemostasis.
In our normal material of 379 blood donors,3 indivi-uals had values below mean −2.5 SD (below 56%).Further studies revealed hereditary deficiency in two of these individuals. In the family study,5 out of 7 individuals had heparin cofactor II (HC II
Autor:
T R, Andersson, O, Hetland
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 95(25)
Autor:
T R, Andersson, J L, Svennevig
Publikováno v:
Clinical and experimental immunology. 44(1)
Mononuclear cells were isolated from peripheral blood and analysed with T and B markers (E rosettes and SIg) and on contaminating monocytes and PMN. The suspensions contained 63.3 +/- 4.8% T lymphocytes, 11.4 +/- 3.8% B lymphocytes, 9.0 +/- 5.5% null
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 106(4)
Publikováno v:
Folia haematologica (Leipzig, Germany : 1928). 115(3)
The plasma inhibitor(s) of factor VIIa-tissue thromboplastin cooperates with factor Xa. This "Extrinsic Pathway Inhibitor" has been quantitated with a sensitive chromogenic substrate assay. Gel filtration of plasma separates 3 EPI peaks. Postoperativ
Publikováno v:
Acta chirurgica Scandinavica. 155(8)
Serial determinations of plasma coagulation inhibitor levels were performed with chromogenic substrate activity assays in 7 patients with cancer. At time of diagnosis normal median activities of Antithrombin, Protein C, Heparin Cofactor II and Extrin